CRIS Current Research Information System

BONIFAZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.837
EU - Europa 2.426
AS - Asia 659
AF - Africa 160
SA - Sud America 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.830
IT - Italia 558
GB - Regno Unito 483
SE - Svezia 439
DE - Germania 287
VN - Vietnam 233
CN - Cina 188
UA - Ucraina 117
IN - India 116
IE - Irlanda 112
TG - Togo 79
FR - Francia 71
RU - Federazione Russa 68
BG - Bulgaria 51
JO - Giordania 51
AT - Austria 50
CH - Svizzera 47
FI - Finlandia 41
ZA - Sudafrica 27
BE - Belgio 25
CI - Costa d'Avorio 24
EE - Estonia 24
NG - Nigeria 21
JP - Giappone 15
IR - Iran 11
NL - Olanda 9
SC - Seychelles 8
CA - Canada 7
HR - Croazia 7
TR - Turchia 7
CL - Cile 6
ES - Italia 6
HK - Hong Kong 6
AU - Australia 5
DK - Danimarca 5
PT - Portogallo 5
RO - Romania 5
BD - Bangladesh 4
BR - Brasile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
KR - Corea 3
LB - Libano 3
PK - Pakistan 3
SG - Singapore 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
EC - Ecuador 1
HU - Ungheria 1
ID - Indonesia 1
KW - Kuwait 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
UG - Uganda 1
Totale 6.099
Salva come PNG Salva come JPEG
Città #
Chandler 456
Southend 416
Fairfield 300
Ashburn 194
Ann Arbor 184
Dong Ket 172
Bologna 155
Woodbridge 144
Wilmington 138
Seattle 133
Houston 124
Princeton 119
Dublin 111
Cambridge 83
Jacksonville 79
Lomé 79
New York 69
Amman 51
Sofia 51
Bremen 46
Berlin 45
Bern 42
Helsinki 40
Nanjing 40
Westminster 40
Vienna 36
Beijing 34
Florence 32
Turin 31
Padova 29
Milan 28
Brussels 25
Abidjan 24
Redmond 24
Saint Petersburg 24
San Diego 24
Abeokuta 21
Hebei 16
Mülheim 14
Boardman 12
Medford 12
Nanchang 12
Reggio Emilia 12
Jinan 11
Norwalk 11
Tokyo 11
Los Angeles 10
Redwood City 10
San Francisco 9
Verona 9
Changsha 8
Haikou 8
London 8
Mahé 8
Pune 8
Olalla 7
Rome 7
Des Moines 6
Falls Church 6
Ferrara 6
Hangzhou 6
Hong Kong 6
Jiaxing 6
Ningbo 6
Paris 6
Ravenna 6
Washington 6
Bari 5
Dearborn 5
Mountain View 5
Shenyang 5
Tianjin 5
York 5
Andover 4
Fukushima 4
Lanzhou 4
Lisbon 4
Madrid 4
Parma 4
Sacramento 4
Taizhou 4
Amsterdam 3
Assisi 3
Bolzano 3
Castellaneta 3
Como 3
Dehradun 3
Faenza 3
Fremont 3
Groningen 3
Istanbul 3
Leawood 3
Moscow 3
Mumbai 3
Napoli 3
Nocera Inferiore 3
Orange 3
Phoenix 3
São Paulo 3
Taipei City 3
Totale 4.025
Salva come PNG Salva come JPEG
Nome #
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 247
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 188
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 172
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 161
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 158
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 156
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 147
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 143
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 139
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 139
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 134
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 128
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 127
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 127
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 125
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 124
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. 122
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 118
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 117
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 117
GVHD and prognostic factors. 116
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 116
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 115
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 113
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 113
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 112
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 109
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 108
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 107
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. 98
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 98
Stem cell mobilization and collection in patients with liver cirrhosis. 97
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 92
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 91
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 87
Digitisation of temporary exhibitions: the Aldrovandi case 86
null 86
null 83
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 82
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 82
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 78
Conjunctival epithelial cells (CEC) morphology in hematological patients before and after hematopoietic stem cell transplantation (HSCT). A Cytological and Confocal Microscopy Study 76
null 75
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 73
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 70
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). 68
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 64
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 62
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 61
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 58
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 53
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 50
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 49
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 47
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 45
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 43
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 40
Ribosomal DNA instability: An evolutionary conserved fuel for inflammaging 39
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 38
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 38
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient 35
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 32
The role of extracellular DNA in COVID-19: Clues from inflamm-aging 28
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 26
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 24
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia 24
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 23
Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation 22
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 18
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection 17
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review (Journal of Neurology, (2022), 269, 8, (4560-4563), 10.1007/s00415-022-11117-8) 16
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 9
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 9
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma 8
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 4
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 3
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 1
Development and initial validation of a questionnaire to assess patients’ perception of protective isolation following haematopoietic stem cell transplantation 1
Totale 6.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019106 0 0 0 0 0 0 0 0 0 46 31 29
2019/20201.122 166 33 18 69 124 115 120 157 137 78 60 45
2020/2021791 129 44 16 22 36 45 7 52 60 48 57 275
2021/20221.418 78 36 73 152 96 46 49 119 84 143 331 211
2022/20231.931 216 282 106 250 125 151 56 103 301 41 194 106
2023/2024670 56 85 63 105 64 175 25 44 15 38 0 0
Totale 6.307